Fasting glucose varies more within one person than HbA1c. A single borderline reading may not represent a stable pattern.

Recent illness, stress, activity, medicines and sample handling can change the value. Similar inherited tendencies can therefore look different.

A current laboratory measurement, repeated when indicated, plus HbA1c or glucose-tolerance testing shows the present pattern. DNA cannot diagnose diabetes.

Scratching can damage the barrier further, sustaining an itch-scratch cycle. The cycle reflects active skin biology, not inherited tendency alone.

Barrier differences can raise susceptibility, while immune activity and exposures shape where and when eczema appears.

Current itch, rash pattern, duration, triggers and skin examination determine relevance. No single blood or genetic test establishes the diagnosis.

DXA measures areal bone mineral density. It does not capture every aspect of bone quality or an imminent fracture.

Age, prior fragility fracture, menopause, glucocorticoids, body weight and smoking can separate inherited tendency from current fracture risk.

A current fracture-risk assessment combines history and clinical factors, with DXA when indicated. DNA cannot diagnose osteoporosis or predict fracture timing.

Eye allergy often travels with rhinitis, asthma or eczema, but each condition still needs its own symptom history.

Ordinary care starts with trigger awareness and symptom-led review. Pain, light sensitivity or reduced vision needs prompt clinical assessment.

Reference positions use a Normal approximation within the named 1,022-person Open-EUR plus Harvard PGP group. This descriptive comparison has no independent predictive validation and cannot establish diagnosis or absolute risk.

Sensitisation requires exposure, so inherited tendency cannot name the substance responsible for an individual rash.

Irritant dermatitis and allergic dermatitis can look similar. Exposure history, examination and patch testing separate them.

Reference positions use a Normal approximation within the named 1,022-person Open-EUR plus Harvard PGP group. This descriptive comparison has no independent predictive validation and cannot establish diagnosis or absolute risk.

A usual meal changes triglycerides more than most other routine lipid measures. Meal timing therefore matters when comparing readings.

Alcohol, recent food, metabolic state, illness and some medicines can shift triglycerides. Similar inherited tendencies can produce different current values.

A current lipid panel, sampling context and repeat measurement when indicated show the present pattern. DNA cannot establish severity or treatment need.

For Stress fracture, the most useful next step is simple: Check: Vitamin D and calcium context.

Genes often influence how kidneys and other tissues handle urate. They do not show whether crystals are present today.

Kidney function, medicines, alcohol, diet, body composition, and illness can change urate or flares. Similar inherited tendencies need not match.

Current joint symptoms, examination, serum urate, and sometimes joint-fluid microscopy or imaging determine present relevance. DNA cannot diagnose gout.

MCH asks how much hemoglobin each cell carries. MCHC asks how densely that hemoglobin is packed inside the cell.

MCH can fall before MCV and may be a more sensitive iron-restriction clue. It still cannot identify the cause by itself.

A current blood count, ferritin, transferrin saturation and clinical context show whether the pattern matters. DNA cannot establish anaemia, deficiency or treatment need.

GGT is absent from bone, so an accompanying GGT rise supports a liver source for raised alkaline phosphatase.

Bone growth, pregnancy, fractures, medicines and bile-flow problems can alter this enzyme. Similar values can therefore have different explanations.

A current alkaline phosphatase and GGT pattern, other liver tests and clinical context determine present relevance. DNA cannot identify the source.

OCT examines optic-nerve structure, while visual fields test function. One pressure reading cannot replace either assessment.

Age, family history, ancestry, steroid exposure and eye anatomy can separate inherited tendency from current optic-nerve health.

Current eye-pressure, optic-nerve, OCT and visual-field assessment when indicated show present disease. DNA cannot diagnose glaucoma or current vision loss.

Rhinitis, asthma and eczema share some genetic architecture. Co-occurrence is possible, but one condition does not prove another.

A positive skin or blood IgE test shows sensitisation. It only supports allergy when exposure and symptoms align.

A current symptom pattern, exposure timing and nasal examination, with targeted allergen testing when needed, determine whether allergic rhinitis fits.

Upper-airway inflammation can disturb sleep and daytime energy when symptoms are active.

Persistent symptoms are assessed through history and examination, with imaging or specialist review reserved for appropriate clinical situations.

Reference positions use a Normal approximation within the named 1,022-person Open-EUR plus Harvard PGP group. This descriptive comparison has no independent predictive validation and cannot establish diagnosis or absolute risk.

Some neutrophils temporarily cling to vessel walls. Stress hormones or corticosteroids can release more into circulation without creating new cells.

Infection, medicines, smoking, and inherited background can shift the measured baseline. Similar genetic tendencies can therefore look different.

A current absolute neutrophil count, repeat measurements, medicines, and infection history show whether the pattern matters. DNA alone cannot establish neutropenia.

Small cells do not automatically mean low iron. MCV loses specificity when chronic disease or an inherited hemoglobin condition is present.

Vitamin B12 or folate deficiency can mask the smaller-cell pattern of iron restriction. Similar MCV values need not share one cause.

A current blood count, ferritin and any indicated follow-up tests show what the cell-size pattern means. DNA cannot diagnose deficiency or a blood disorder.

Albumin leakage and eGFR are separate kidney dimensions. One may be abnormal while the other is not.

Exercise, infection, blood in urine and menstruation can temporarily raise the ratio. Repeated results can therefore differ.

A repeat urine albumin-to-creatinine ratio and current eGFR determine present relevance. DNA cannot establish persistent albuminuria or its cause.

Atrial fibrillation can come and go, so normal rhythm between episodes does not exclude it. Timing determines which recording can capture it.

Age, blood pressure, sleep apnea, alcohol exposure and heart conditions modify susceptibility. Family history adds context without confirming atrial fibrillation.

Current symptoms, pulse or wearable alerts need ECG confirmation during clinical assessment. DNA cannot diagnose atrial fibrillation or choose treatment.

ANA is sensitive but not specific. Many people with a positive test do not have lupus, so the full clinical pattern matters.

Ancestry, sex, hormones, exposures and other inherited factors influence onset and organ pattern. One tendency cannot predict a person's course.

Current symptoms, examination, urine, blood counts, kidney function, complement and disease-specific antibodies determine relevance. DNA cannot diagnose lupus.

A raised ‘liver enzyme’ can sometimes be an exercise finding rather than a liver finding.

Alcohol exposure, medicines, liver conditions and recent exercise can create different AST patterns between people.

A current liver blood panel and relevant muscle, medicine and exposure history determine present relevance. DNA cannot supply today's AST.

Humans lost functional uricase, leaving us with higher urate than many other mammals.

Kidney excretion, medicines, alcohol, diet and metabolic state can change urate. Similar inherited tendencies can therefore lead to different levels.

A current serum urate, kidney function, medicine history and any flare pattern show whether this matters now. DNA cannot diagnose gout or set treatment.

Gallstone pain usually begins when a stone blocks bile flow, not simply because a stone exists.

Stone chemistry, gallbladder emptying, body-weight changes and blood-cell breakdown help explain why stones form differently between people.

Current pain pattern, fever, jaundice, liver tests and ultrasound guide assessment. DNA cannot show stones or decide whether surgery is needed.

Insomnia biology points toward wakefulness as much as sleep: inherited patterns involve brain cells that regulate arousal.

The brain areas highlighted help regulate arousal, sleep timing and awareness of internal sensations. That may help explain the experience of feeling tired while the mind and body remain alert.

A two-week diary records bedtime, awakenings, wake time and daytime function. DNA cannot establish whether insomnia is present or identify causes such as pain, medication, shift work or sleep apnoea.

Vitamin E travels with lipids, so a higher blood value can partly reflect lipid transport rather than nutritional status.

DNA cannot define current dietary intake, tissue status or supplement need from an inherited plasma tendency.

A current alpha-tocopherol interpreted with circulating lipids, diet, supplements and clinical context determines present relevance.

Less than one percent of body magnesium is in serum. Kidneys keep that small circulating pool under tight control.

Food intake, gut absorption, kidney handling, medicines and losses can move present status independently of inherited tendency.

A current serum measurement, intake and medicine history, kidney context and symptoms guide interpretation. DNA cannot show tissue stores or supplement need.

A week of wrist data from 91,105 people found that inherited influences on movement were real but highly dispersed. The strongest individual DNA findings explained only 0.06% of activity differences.

The study pointed towards the brain as well as the body. That may help explain why being capable of exercise and actually moving through the day are different traits.

One week of device data describes current movement better than DNA. Weather, work, caring duties, illness, access and habit can move activity far beyond an inherited tendency.

Routine liver blood tests and fibrosis tests answer different questions. Enzyme activity does not directly measure the amount of scarring.

Metabolic health, alcohol exposure, viral infection, autoimmunity and medicines can lead toward similar scarring through different routes.

Current history, liver tests, platelet count, imaging and fibrosis assessment determine relevance. DNA cannot diagnose cirrhosis or identify its cause.

EPA can be converted into E-series resolvins and other signalling lipids. A blood EPA value cannot show their activity.

Recent intake, longer-term diet, metabolism, and sample type can alter measured EPA. Similar inherited tendencies can produce different levels.

A current, clearly specified EPA measurement makes most sense beside recent intake, supplement use and the sampled lipid pool. DNA alone cannot establish deficiency or treatment need.

Thyroid antibodies can appear while TSH and free T4 remain normal, so susceptibility, immunity and function can diverge.

Antibodies can persist for years while TSH and free T4 stay within range. Some people later develop hypothyroidism; others do not. Antibody status and current function therefore need separate readings.

The 2026 study linked Hashimoto's signals with immune cells, T cells and thyroid tissue. HLA proteins help immune cells show protein fragments to T cells. This shared biology may help explain why autoimmune conditions sometimes cluster in families.

Different tasks emphasise visual detection, decision or motor speed. Their measurements are related, but they are not interchangeable.

Controlled sleep restriction produced cumulative attentional lapses and slower responses. Present sleep can therefore outweigh a modest inherited tendency.

A current repeated, standardised task with sleep and sensory context provides direct evidence. DNA cannot measure intelligence or current performance.

The discovery of H. pylori changed ulcers from an acid-only story to one often driven by treatable infection.

Ulcers can remain silent until bleeding. Upper abdominal pain cannot reliably distinguish an ulcer from other digestive conditions.

Current symptoms, bleeding signs, medicine use, H. pylori testing and sometimes endoscopy establish the cause. DNA cannot diagnose or select treatment.

In the HERITAGE study, 481 sedentary adults completed the same 20-week endurance programme. Average VO2max rose by about 400 millilitres per minute, but individual change varied widely.

Some people showed little change; others gained more than one litre per minute. Responses clustered within families, suggesting inherited biology affects trainability without predicting who will improve most.

The study included white families and cannot set expectations for everyone. A measured baseline and repeat test after consistent training show personal capacity and change; DNA cannot substitute for either.

In balloon-distension studies, pressures felt as mild by controls could be painful for people with IBS.

Motility, gut sensitivity, infections and brain-gut signalling can create different symptom patterns between people.

A symptom diary, examination and selected blood or stool tests help assess mimics. DNA cannot confirm IBS or choose a diet.

In a 66-person study, stool form tracked transit changes better than frequency. Harder form generally accompanied slower transit.

Pain and bloating help distinguish IBS with constipation from functional constipation. Transit time alone may not separate them.

Current stool pattern, medicines, bleeding, anaemia, weight change and screening history guide assessment. DNA cannot diagnose the cause or select treatment.

Pain and pancreatic damage do not always move together. Symptoms alone cannot confirm or stage the disease.

Smoking, alcohol exposure, duct problems, immune disease and uncommon inherited changes can combine differently between people.

Pancreatitis history, current symptoms, imaging and pancreatic-function tests determine relevance. DNA cannot diagnose chronic pancreatitis or select treatment.

An abdominal aneurysm can remain silent for years, so absence of pain does not show the aorta is normal.

Screening eligibility varies with age, sex, smoking history and family history. Sudden severe abdominal or back pain needs urgent clinical assessment.

Current abdominal ultrasound, when screening criteria or symptoms support it, determines whether an aneurysm is present and measures its diameter.

Blood acetate reflects production, absorption and metabolism across compartments. A plasma assay cannot isolate dietary fibre or one microbial pathway.

Large genetic studies identify inherited influences on circulating acetate. They do not establish today's concentration, gut health or dietary need.

A current plasma acetate measured under a defined protocol, alongside diet, alcohol, medicines and symptoms, determines present relevance.

In six men, high-intensity cycling raised muscle short-chain acylcarnitines substantially. Plasma changes did not mirror muscle changes reliably.

An inherited plasma tendency cannot diagnose mitochondrial dysfunction, impaired fat use or exercise capacity.

A current plasma acylcarnitine profile, sampling conditions, symptoms and clinician-selected metabolic assessment determine present relevance.

Genetic studies sometimes combine painful tendinopathy with rupture. Those outcomes still need separate clinical assessment.

Pain location, onset, function and examination help distinguish tendinopathy, rupture and other causes. Imaging is selective rather than automatic.

A current symptom and loading history with physical examination, plus ultrasound or MRI when indicated, determines the present tendon condition.

Inherited susceptibility may influence follicle development and inflammation, but it does not identify today's lesion type or severity.

Lesion type, extent, scarring, age and medicine or hormonal context shape clinical interpretation.

A current skin examination with lesion distribution, scarring and relevant medicine history determines present severity and whether another condition fits.

Clinical diagnosis generally requires two features: characteristic pain, substantially raised pancreatic enzymes, or characteristic imaging.

Imaging is not required solely to confirm every typical presentation. It helps when diagnosis is uncertain or complications are considered.

A current clinical assessment with serum lipase, plus abdominal imaging when indicated, determines whether acute pancreatitis is present.

Early macular degeneration genetics overlaps partly with advanced disease, but prediction across stages and ancestries remains limited.

Fundus examination identifies drusen and pigment changes. Optical coherence tomography shows retinal layers and fluid when wet disease is suspected.

Current fundus examination, vision assessment and optical coherence tomography when indicated determine whether macular degeneration is present and its stage.

The condition spans fat accumulation, inflammation, and cirrhosis. Each stage requires clinical evidence.

Exposure pattern, nutrition, metabolic health, viral infection, age, sex, and other factors shape susceptibility.

Current alcohol history, liver tests, imaging, examination, and sometimes biopsy determine relevance. DNA alone cannot diagnose liver disease.

The mechanisms differ by organ. Too little circulating protection affects lungs, while retained abnormal protein can injure liver cells.

Smoking and other lung exposures can amplify respiratory vulnerability. Metabolic liver stress can modify liver expression.

Current alpha-1 antitrypsin concentration, protein phenotype, confirmatory genetics, lung history, and liver markers provide the direct check.

The size of an ALT rise does not map neatly to disease severity. Pattern, cause and change over time matter.

AST, ALP, GGT, bilirubin and albumin answer different questions. Their combined pattern can narrow what needs assessment.

A current liver blood panel, medicine history and repeat testing when appropriate determine present relevance. DNA cannot supply today's ALT.

Morning stiffness, night pain, improvement with movement, heel pain, uveitis, psoriasis and bowel inflammation can form one clinical pattern.

Normal inflammatory markers or negative HLA-B27 do not exclude axial spondyloarthritis. Plain X-rays can also be normal early.

A current symptom history, examination, inflammatory markers and sacroiliac imaging, interpreted by rheumatology, determine whether axial spondyloarthritis is present.

ApoB and LDL cholesterol answer related but different questions; neither can be reconstructed from the other perfectly.

Triglyceride-rich states can create more cholesterol-poor particles. This is one reason ApoB may disagree with LDL or non-HDL cholesterol.

A current lipid panel with ApoB shows whether particle number is raised now. DNA cannot provide today's concentration or determine treatment.

Lean tissue quantity and muscle strength can change differently over time. Measuring one cannot substitute for measuring the other.

Current sarcopenia definitions separate strength, muscle quantity and physical performance. Each answers a different question about present function.

Body-composition measurement, grip strength and performance tests show current status. DNA cannot diagnose sarcopenia or prescribe protein intake or training.

Betaine donates a methyl group that helps recycle homocysteine to methionine. This route works mainly in the liver and kidneys.

Dietary betaine, choline intake, liver metabolism and kidney handling can separate similar inherited tendencies from current levels.

A current plasma betaine measurement, intake history and relevant health data resolve present relevance. DNA cannot establish deficiency or supplement need.

Genetic findings track bone density much better than they track actual fractures.

Falls, bone shape, age, medicines and previous fractures help explain why similar density can lead to different outcomes.

A current DXA scan, age, fracture history, medicines and fall risk determine present relevance. DNA cannot measure bone strength.

Colon cells and liver remove much short-chain fatty acid before peripheral sampling. Butyrate is especially affected by first-pass use.

The inherited signal describes a combined plasma assay. It cannot reveal microbiome composition, fibre intake or gut symptoms.

A current isomer-resolved plasma measurement, sampling conditions, diet and symptoms determine present relevance, if testing is clinically warranted.

CRP has a fairly constant blood half-life. Its concentration mainly tracks how quickly the liver is producing it.

Recent illness, tissue injury, and other inflammation can shift measured CRP. Similar inherited tendencies can therefore produce different results.

A current CRP measurement, recent health context, and repeat testing when appropriate show whether inflammation is present now. DNA cannot identify its cause.

Celiac disease is an autoimmune response to gluten, not wheat allergy or ordinary food intolerance.

A first-degree celiac family history or certain autoimmune conditions increase testing relevance. Genetics cannot show whether intestinal injury is present.

Blood testing starts with tTG-IgA and total IgA while gluten remains in the diet. Discuss testing before dietary changes; DNA cannot diagnose.

Recycling and microbial conversion mean one plasma value represents only one compartment and time point.

An inherited plasma tendency cannot diagnose liver disease, malabsorption, gallbladder disease or microbiome activity.

A current liver blood panel and clinician-selected bile-acid testing, interpreted with symptoms and medicines, determine present relevance.

Controlled depletion studies found substantial variation in organ responses. They do not support one supplement rule for every person.

An inherited plasma tendency cannot establish intake, deficiency, individual requirements or supplement benefit.

A current dietary assessment and clinician-selected choline-related tests, interpreted with liver and nutrition context, determine present relevance.

Albumin can leak into urine while filtration remains preserved. Conversely, reduced filtration can occur without marked albumin leakage.

Diabetes, blood pressure, age, medicines and acute illness affect kidney measurements and progression. Inherited tendency is only one contributor.

Repeated eGFR, urine albumin-to-creatinine ratio and clinical history determine present relevance. DNA cannot diagnose CKD or establish its cause.

Injury, inflammation, nerves, migraine, joints, sleep, mood, and central processing can create different pain pathways.

Multisite pain studies capture broad susceptibility across heterogeneous experiences. They do not identify one cause for an individual.

Current pain pattern, duration, function, examination, and clinical history determine relevance. DNA alone cannot diagnose chronic pain.

Morning light tends to move the body clock earlier; evening light tends to move it later.

Social jetlag is the mismatch between preferred and required timing. It can occur even when total sleep appears adequate.

A sleep diary across work and free days shows current timing and mismatch. DNA cannot assign a fixed morning-person or evening-person identity.

Atherosclerosis develops over years before symptoms, while a heart attack is an acute complication. Those timeframes answer different questions.

Blood pressure, cholesterol, blood sugar, smoking exposure, age and family history modify inherited susceptibility throughout life.

Current symptoms, measured risk factors and clinically selected heart tests determine relevance. DNA cannot diagnose obstruction or choose treatment.

In ten healthy adults sampled every 15 minutes, cortisol showed circadian and pulse-like variation across 24 hours.

The inherited plasma tendency cannot replace morning, late-night, suppression or urinary testing chosen for different clinical questions.

A current time-defined cortisol test, medicine history and clinical question determine present relevance. DNA cannot establish today's hormone pattern.

After the same eccentric exercise, CK responses varied widely between participants. Soreness and strength changes did not align perfectly.

Recent strenuous exercise, muscle injury and medicines can outweigh inherited background when interpreting one measurement.

A current CK, symptoms, recent exercise, medicine history and repeat testing when indicated determine present relevance.

Unlike IBS, Crohn's produces objective inflammation and can damage bowel tissue. Similar pain or diarrhea can therefore have different meanings.

Immune responses, microbes, smoking and other exposures modify inherited susceptibility. Genetic associations cannot predict one person's disease location or course.

Current symptoms, blood and stool inflammation tests, endoscopy and imaging establish relevance. DNA cannot confirm Crohn's or select a diet.

Creatinine and cystatin C have different sources of error. Combining them is often more accurate than using either marker alone.

Inflammation, thyroid function, smoking, body composition and some medicines can influence cystatin C beyond filtration. Measured values can therefore differ.

A current combined creatinine-cystatin C eGFR, urine albumin-to-creatinine ratio and clinical context determine present relevance. DNA cannot supply current filtration.

Feeling sleepy enough to doze differs from feeling exhausted without sleep pressure. That distinction changes which current evidence matters.

Associated variants grouped into sleep-propensity and sleep-fragmentation patterns. Similar daytime sleepiness can therefore arise through different pathways.

Current sleep, schedule, snoring, medicines, naps and unintended dozing guide assessment. DNA cannot diagnose sleep apnea or explain dangerous sleepiness.

Caries is dynamic: mineral loss and repair alternate repeatedly before a cavity forms. Pain can be absent during early disease.

Tooth shape, saliva flow, microbial ecology, diet, fluoride and access to dental care all modify susceptibility.

A dental examination, symptoms and sometimes radiographs show present disease and hidden lesions. DNA cannot reveal cavities or determine dental care.

A molecule beginning in the liver can be chemically rewritten in the gut, then returned through enterohepatic circulation.

Gut microbes, diet, liver handling, and meal timing can change deoxycholate. Similar inherited tendencies need not produce matching levels.

A current bile-acid measurement, specimen type, meal timing, and relevant digestive or liver history determine present relevance. DNA cannot diagnose bile-acid disease.

Different samples reflect different timescales. Plasma changes within days, while some cell and tissue pools change over months.

Diet, supplements, absorption, conversion, and sampled lipid pool can change measured DHA. Similar inherited tendencies need not match.

A current, clearly specified DHA measurement makes most sense beside longer-term intake, supplement use and the sampled lipid pool. DNA alone cannot establish deficiency or supplement need.

In a controlled transit study, looser stool form accompanied faster movement through the gut. Frequency was a weaker guide.

Persistent watery diarrhea can reflect celiac disease, Giardia infection, bile-acid diarrhea or inflammation. Similar stools can therefore have different causes.

Duration, stool form, exposures, medicines, hydration, bleeding, weight change and nocturnal symptoms guide testing. DNA cannot identify the cause or treatment.

Home, clinic, and ambulatory readings sample different conditions. Their averages can disagree without any genetic change.

Activity, stress, sleep, medicines, and illness can alter current pressure. Similar inherited tendencies can therefore produce different readings.

Repeated readings with a validated cuff and correct technique show the current pattern. Clinical review interprets both numbers together. DNA cannot diagnose hypertension.

The same enlarged, weakened pattern can arise through different routes. Imaging shows the phenotype, while clinical assessment investigates its cause.

Family history, symptoms, exposures, rhythm, and other heart conditions change interpretation. Similar inherited tendencies can produce different outcomes.

Current symptoms, examination, ECG, echocardiography, and sometimes cardiac MRI determine present relevance. DNA alone cannot diagnose dilated cardiomyopathy.

In 47,228 men followed for 18 years, nuts, corn and popcorn did not increase diverticular complications.

Persistent lower-left pain with bowel changes differs from sudden severe pain with fever. Rectal bleeding creates another clinical question.

Current symptoms, examination, blood tests and imaging when indicated distinguish these states. DNA cannot show pouches, inflammation or bleeding.

Eosinophils follow a daily rhythm, often falling in the morning and rising later. Sampling time can change the number.

Corticosteroids can lower blood eosinophils quickly. Exposure, infection, and treatment can make similar inherited tendencies look different.

A current absolute eosinophil count, symptoms, exposure and medicine history, and repeat testing show present relevance. DNA cannot diagnose allergy.

Adults often notice swallowing difficulty or food sticking. Children can show feeding problems, vomiting, or poor growth.

Genes, allergens, and other environmental factors can contribute. Similar inherited tendencies need not produce the same disease.

Current oesophageal symptoms, endoscopy, and biopsies from multiple levels establish present relevance. DNA cannot diagnose eosinophilic oesophagitis.

Erections depend on coordinated nerve signals and blood flow. A vascular change can affect function before other circulation symptoms appear.

Large genetic studies find common susceptibility signals, yet each has modest effects. Diverse mechanisms keep DNA from determining individual experience.

Current sexual history, symptoms, medicines, cardiovascular health, metabolic measures, hormones, and clinical assessment provide the direct relevance check.

Kidney assessment has two axes: filtration and albumin leakage. One can change while the other remains normal.

Cystatin C has different non-filtration influences from creatinine. Combining both markers usually brings the estimate closer to measured GFR.

A current eGFR, urine albumin-to-creatinine ratio and repeat testing when indicated determine present relevance. DNA cannot establish current kidney function.

Low ferritin usually suggests depleted stores; high ferritin can reflect inflammation, liver disease or iron loading.

Inflammation, liver conditions and iron loading can raise ferritin through different routes, even when stored iron is not depleted.

Current ferritin, transferrin saturation, inflammation markers, liver context and a blood count decide what the value means. DNA cannot establish current stores or treatment need. Reference positions use a Normal approximation within the named 1,022-person Open-EUR plus Harvard PGP group. This descriptive comparison has no independent predictive validation and cannot establish diagnosis or absolute risk.

Hand symptoms depend on joint use, prior injury, age and other factors as well as inherited susceptibility.

Examination and function guide care. This tendency does not predict surgery or determine treatment.

Reference positions use a Normal approximation within the named 1,022-person Open-EUR plus Harvard PGP group. This descriptive comparison has no independent predictive validation and cannot establish diagnosis or absolute risk.

Folate carries one-carbon units needed to make DNA and red blood cells. Its role is broader than one popular gene.

Food fortification, alcohol exposure, absorption and medicines can separate similar inherited tendencies from measured status.

Current serum or red-cell folate and intake history show present status. DNA cannot establish deficiency or determine supplement need.

TSH and free T4 are interpreted together because the pituitary and thyroid respond to each other.

Measured tests and clinical context decide whether follow-up is useful. Genetics cannot establish a current hormone concentration or treatment need.

Reference positions use a Normal approximation within the named 1,022-person Open-EUR plus Harvard PGP group. This descriptive comparison has no independent predictive validation and cannot establish diagnosis or absolute risk.

The condition reflects gut sensation and movement as well as interactions with meals and stress.

Persistent or changing symptoms need symptom-led review, especially with weight loss, bleeding, vomiting or difficulty swallowing.

Reference positions use a Normal approximation within the named 1,022-person Open-EUR plus Harvard PGP group. This descriptive comparison has no independent predictive validation and cannot establish diagnosis or absolute risk.

Occasional reflux is common; disease depends on symptom burden or complications. Endoscopy can be normal despite clinically important reflux.

Heartburn and regurgitation are typical, but chest discomfort has other causes. Swallowing difficulty, bleeding, persistent vomiting or weight loss need review.

Current symptoms, medicines, response history and sometimes endoscopy or reflux monitoring establish relevance. DNA cannot diagnose reflux or prescribe acid suppression.

GGT is not found in bone. That makes it useful when alkaline phosphatase could come from either liver or bone.

Alcohol exposure, body composition and medicines can alter GGT. Similar inherited tendencies can therefore produce different measured values.

A current GGT, alkaline phosphatase, wider liver panel and relevant history determine present relevance. DNA cannot supply today's GGT.

Bleeding can flag inflammation, but diagnosis also considers probing depth, attachment loss and radiographic bone loss.

Plaque exposure, smoking, glycaemia and dental history can separate inherited tendency from current periodontal disease.

A current dental examination with periodontal probing, and radiographs when indicated, shows present tissue support. DNA cannot diagnose active periodontitis.

The same molecule serves metabolism throughout the body and signalling inside the brain. Location changes what a glutamate measurement means.

Meals and time of day can alter blood glutamate. Sample handling can affect metabolomic results more broadly.

A current, well-handled blood measurement, sampling conditions, and relevant clinical context determine present relevance. DNA cannot establish a neurological condition.

Glutamine carries nitrogen between tissues. Skeletal muscle stores and releases much of the body's glutamine supply.

Feeding, fasting, exercise and severe illness can change production and demand, separating inherited tendency from a present measurement.

If clinically measured, plasma glutamine makes sense beside recent intake, illness or exercise stress, and why it was checked. DNA cannot establish a gut problem or supplement need.

Glycine helps build glutathione and supports one-carbon metabolism. One circulating value therefore reflects several sources and uses.

Recent intake, fasting state, liver metabolism and metabolic health can separate similar inherited tendencies from measured glycine.

If clinically measured, plasma glycine makes sense beside recent intake, fasting state and broader metabolic context. DNA cannot establish deficiency or supplement need.

Conjugation makes bile acids more water-compatible before secretion. Gut microbes can later remove or further transform that chemical tag.

Meal timing, liver uptake, intestinal reabsorption, and microbial transformations can change glycocholate. Similar inherited tendencies need not produce matching levels.

A current bile-acid measurement, specimen type, meal timing, and relevant liver or digestive history determine relevance. DNA cannot diagnose impaired bile flow.

Grip combines force from muscles, nerves and joints. One hand measurement cannot capture balance, endurance or power.

In 139,691 adults across 17 countries, lower grip tracked poorer health outcomes. This observational association does not prove grip weakness caused them.

Repeated dynamometer and functional tests show current strength and change. DNA cannot diagnose frailty or choose a training load.

Medicines have raised HDL cholesterol without reliably reducing cardiovascular events.

Smoking exposure, activity, medicines and metabolic state can change HDL cholesterol. Similar inherited tendencies can therefore produce different readings.

A current lipid panel, especially triglycerides, non-HDL cholesterol and ApoB, shows the present pattern. DNA cannot establish cardiovascular risk or treatment.

Different routes can converge on the same syndrome, including coronary disease, high blood pressure, rhythm disorders, valve disease, or cardiomyopathy.

Age, kidney function, illness, exposures, and other heart conditions shape current risk. Similar inherited tendencies need not produce matching outcomes.

Current symptoms, examination, natriuretic peptides, ECG, and echocardiography determine present relevance. DNA cannot diagnose heart failure or identify its cause.

Two people can share the same average heart rate while having very different variation between successive beats.

Breathing, posture, sleep, time and recording length affect HRV. Comparing repeated readings requires a consistent metric and setting.

One device, metric and routine can show current trends. DNA cannot diagnose autonomic dysfunction or prescribe recovery or training.

Hematocrit can move without the body gaining or losing red cells. A change in the liquid part of blood can shift the percentage.

Red-cell number and average cell size both shape hematocrit. Mean corpuscular volume helps explain which part of that pattern changed.

A current blood count and repeat measurement show the present pattern. DNA cannot establish dehydration, anaemia or excess red-cell production.

Red cells circulate for months, so hemoglobin reflects accumulated production and loss. It is not a reading of today's food or supplement intake.

Two people with the same hemoglobin can have different red-cell sizes and iron stores. The surrounding blood-count pattern explains more than the headline value.

A current blood count, ferritin, transferrin saturation and relevant history show whether oxygen-carrying capacity needs assessment. DNA cannot establish anaemia or its cause.

Replacement in a study endpoint reflects both disease and healthcare decisions, so it is not a pure measure of joint biology.

Symptoms, examination, function and imaging when appropriate determine whether hip osteoarthritis is present and what care is useful.

Reference positions use a Normal approximation within the named 1,022-person Open-EUR plus Harvard PGP group. This descriptive comparison has no independent predictive validation and cannot establish diagnosis or absolute risk.

A lower biomarker is not automatically a better clinical outcome. A large vitamin trial lowered homocysteine without reducing its primary cardiovascular outcome.

Vitamin status, kidney function, medicines, age, and genetics can change homocysteine. Similar inherited tendencies can therefore produce different results.

A current homocysteine measurement, kidney function, blood count, nutrient tests, medicines, and diet provide the present context. DNA cannot prescribe supplements.

White-coat and masked hypertension point in opposite directions: clinic readings can overstate or miss usual blood pressure.

Home or ambulatory monitoring can separate sustained hypertension from clinic-only elevation. Measurement technique and timing still influence interpretation.

Current validated home, ambulatory or repeated clinic measurements provide direct evidence. DNA cannot confirm hypertension or choose treatment.

Even relatives carrying the same HCM-causing variant can develop very different heart changes.

Even a rare disease-causing variant can show incomplete penetrance. Conversely, some HCM occurs without an identified rare variant.

Current symptoms, family history, electrocardiography and cardiac imaging provide direct evidence. DNA tendency cannot diagnose HCM or predict sudden death.

TSH can rise before free T4 falls, so early and overt hypothyroidism produce different biochemical patterns.

Autoimmunity, thyroid surgery, medicines, iodine exposure and pituitary disease can create different patterns. Similar symptoms can have non-thyroid causes.

Current TSH and free T4, interpreted with symptoms, medicines and life stage, provide direct evidence. DNA cannot diagnose hypothyroidism or select treatment.

Crohn's disease can affect any digestive segment, while ulcerative colitis centres on the colon. Their locations and tissue patterns differ.

Common variants influence immune and barrier pathways, but no polygenic estimate establishes current inflammation. Environment and microbial exposures also contribute.

Current symptoms, blood and stool markers, imaging or endoscopy when clinically indicated provide direct evidence. DNA cannot diagnose IBD or its subtype.

The source phenotype captures the overall diagnosed condition. It does not measure current iron stores or show why deficiency developed.

Supplementation and investigation depend on measured blood tests and clinical context. DNA alone cannot establish either need.

Reference positions use a Normal approximation within the named 1,022-person Open-EUR plus Harvard PGP group. This descriptive comparison has no independent predictive validation and cannot establish diagnosis or absolute risk.

The source phenotype captures the overall diagnosed condition, not a current vitamin concentration or isolated dietary pattern.

Supplement use and investigation depend on measured evidence and the cause. DNA alone cannot establish deficiency or treatment need.

Reference positions use a Normal approximation within the named 1,022-person Open-EUR plus Harvard PGP group. This descriptive comparison has no independent predictive validation and cannot establish diagnosis or absolute risk.

A heart clot, narrowed large artery, or small-vessel disease can produce the same outward event.

Blood pressure, smoking, diabetes, lipids and atrial fibrillation shape current vascular context. DNA does not reveal whether these are present.

Current neurological examination and brain and vessel imaging distinguish ischemia from bleeding after symptoms. DNA cannot identify an acute stroke.

Replacement in a study endpoint reflects both disease and healthcare decisions, so it is not a pure measure of joint biology.

Symptoms, examination, function and imaging when appropriate determine whether knee osteoarthritis is present and what care is useful.

Reference positions use a Normal approximation within the named 1,022-person Open-EUR plus Harvard PGP group. This descriptive comparison has no independent predictive validation and cannot establish diagnosis or absolute risk.

The kynurenine-to-tryptophan ratio is often treated as one enzyme's activity. In living people, several other processes can move that ratio.

Inflammation, nutrition, hormones, liver metabolism, and tissue uptake can alter levels. Similar inherited tendencies can therefore look different.

Current kynurenine and tryptophan measurements, specimen handling, and relevant clinical context determine present relevance. DNA cannot identify their cause.

Cells make lactate even when oxygen is available. Other tissues can burn it or recycle its carbon into glucose.

Recent exercise, blood flow, liver and kidney clearance, medicines and acute illness can separate inherited tendency from measured lactate.

A current lactate measurement needs timing, sample type, recent activity and clinical context. DNA cannot identify lactic acidosis or its cause.

A study of 6,814 adults found that, when LDL-C and particle number disagreed, cardiovascular events tracked particle number more closely. Cholesterol content varies from one LDL particle to another.

People who naturally had 1 mmol/L lower LDL-C throughout life experienced 54.5% less coronary disease in one analysis. The comparison suggests years of exposure matter; it does not promise an individual outcome.

A blood test, medication history and family history show the current picture. DNA cannot supply today's LDL-C or decide whether LDL-C, non-HDL cholesterol and ApoB agree.

Lp(a) usually changes less with meals and everyday habits than triglycerides or LDL cholesterol.

Among 460,506 UK Biobank participants, cardiovascular events rose steadily across the Lp(a) range. Risk increased rather than appearing only above one sharp threshold.

In one large study, a detailed DNA model captured much of the variation in measured Lp(a). Once the blood measurement was known, the DNA model added no further predictive information.

Imaging estimates current fat, while stiffness tests and blood-based indices assess fibrosis. Fat and scarring are related but distinct.

Metabolic health, body-fat distribution, alcohol, medicines and inherited biology can contribute. Similar genetic tendencies can produce different liver findings.

Current liver chemistry, appropriate imaging and fibrosis assessment provide direct evidence. DNA cannot measure today's liver fat or liver injury.

Sleep, infection, pain, mood, medicines, anaemia, thyroid function, and metabolic illness can produce similar fatigue.

Population studies often use one recent tiredness question. That phenotype does not equal ME/CFS or explain an individual's symptoms.

Current duration, activity effects, sleep, function, history, examination, and selected tests determine relevance. DNA alone cannot diagnose fatigue's cause.

Semen analysis separates concentration, movement, shape, and volume. No single threshold cleanly divides fertile from infertile people.

Some severe sperm-production disorders have identifiable genetic causes. Common-variant tendencies cannot substitute for targeted evaluation of those conditions.

Current reproductive history, semen analyses, examination, hormones, health context, and partner evaluation provide the direct relevance check.